Patients’ Experiences and Preferences for Medicine Information: An International Comparison Between Malaysia, Thailand, Uganda, and England

References

• Raynor DT. The importance of medicines information for patients. Prescriber. 2007;18(2):60–62. doi:10.1002/psb.15
   Google Scholar
• Nualdaisri P, Corlett SA, Krska J. Provision and need for medicine information in Asia and Africa: a scoping review of the literature. Drug Saf. 2021;44(4):421–437. doi:10.1007/s40264-020-01038-8
   PubMed Web of Science ®Google Scholar
• Letts M. Always Read the Leaflet Getting the Best Information with Every Medicine. London: TSO (The Stationery Office); 2005.
   Google Scholar
• World Health Organization. Promoting rational use of medicines. Available from: https://www.who.int/activities/promoting-rational-use-of-medicines. Accessed July 3, 2023.
   Google Scholar
• Kusch MKP, Haefeli WE, Seidling HM. How to meet patients’ individual needs for drug information-A scoping review. Patient Prefer Adherence. 2018;12:2339–2355. doi:10.2147/PPA.S173651
   PubMed Web of Science ®Google Scholar
• Ho CN, Ko Y, Tan ML. Patient needs and sources of drug information in Singapore: is the internet replacing former sources? Ann Pharmacother. 2009;43(4):732–739. doi:10.1345/aph.1L580
   PubMed Web of Science ®Google Scholar
• Raynor DK, Blenkinsopp A, Knapp P, et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess. 2007;11(5):1–6.
   Web of Science ®Google Scholar
• Patel S, Dowse R. Understanding the medicines information-seeking behaviour and information needs of South African long-term patients with limited literacy skills. Heal Expect. 2015;18(5):1494–1507. doi:10.1111/hex.12131
   PubMed Web of Science ®Google Scholar
• Raynor DK, Savage I, Knapp P, Henley J. We are the experts: people with asthma talk about their medicine information needs. Patient Educ Couns. 2004;53(2):167–174. doi:10.1016/S0738-3991(03)00126-5
   PubMed Web of Science ®Google Scholar
• Balmer C. The information requirements of people with cancer: where to go after the ‘patient information leaflet’? Cancer Nurs. 2005;28(1):36–46. doi:10.1097/00002820-200501000-00005
   PubMed Web of Science ®Google Scholar
• Krska J, Morecroft CW. Patients’ use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical in-patients. Drug Saf. 2013;36(8):673–680. doi:10.1007/s40264-013-0065-3
   PubMed Web of Science ®Google Scholar
• Saleem H, Ghoto MA, Memon N, Dayo A, Suheryani I, Shafique S. Assessment of patients awareness towards pharmacotherapy and their sources of drug information in different areas of Hyderabad, Pakistan. Int Res J Biol Sci. 2015;4(8):56–59.
   Google Scholar
• Sevikyan A, Kazaryan I, Amirkhanyan A, Melikyan M. Patients’ expectations on receiving medicines information from community pharmacies. Res Soc Adm Pharm. 2017;13(3):e10–e11. doi:10.1016/j.sapharm.2017.02.088
   Google Scholar
• Perera T, Ranasinghe P, Perera U, et al. Knowledge of prescribed medication information among patients with limited English proficiency in Sri Lanka. BMC Res Notes. 2012;5(1):1. doi:10.1186/1756-0500-5-658
   PubMedGoogle Scholar
• Hamrosi KK, Raynor DK, Aslani P. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page? Res Soc Adm Pharm. 2014;10(4):656–668. doi:10.1016/j.sapharm.2013.10.002
   PubMed Web of Science ®Google Scholar
• Liu LST, Goh BQ, Tang WP, Lo FL, Khoo RSY, Lim CJF. Drug information needs and concerns of primary care patients with newly prescribed chronic medications. Proc Singapore Healthc. 2018;27(4):294–298. doi:10.1177/2010105818779605
   Google Scholar
• Dawood OT, Hassali MA, Saleem F, Ibrahim IR. Assessment of self-reporting reading of medicine’s labels and the resources of information about medicines in general public in Malaysia. Pharmacol Res Perspect. 2018;6(2). doi:10.1002/prp2.387
   PubMed Web of Science ®Google Scholar
• Wongtaweepkij K, Krska J, Pongwecharak J, Jarernsiripornkul N. Experiences and views of medicine information among the general public in Thailand. Patient Prefer Adherence. 2020;14:1073–1082. doi:10.2147/PPA.S257454
   PubMed Web of Science ®Google Scholar
• Amin MEK, Chewning BA, Wahdan AMH. Sources of drug information for patients with chronic conditions in Alexandria, Egypt. Int J Pharm Pract. 2011;19(1):13–20. doi:10.1111/j.2042-7174.2010.00069.x
   PubMedGoogle Scholar
• Afolabi MO, Akinwale VO, Akinyemi OA, Irinoye AI. Patient use and perception of medicine information leaflets. Pharmacoepidemiol Drug Saf. 2012;21(1):110.
   Web of Science ®Google Scholar
• O’Donovan B, Rodgers RM, Cox AR, Krska J. Use of information sources regarding medicine side effects among the general population: a cross-sectional survey. Prim Heal Care Res Dev. 2019;20(e153):1–9.
   Google Scholar
• European Commission. Guideline on the readability of the label and package leaflet of medicinal products for human use. EC Pharmaceuticals Committee. 2009. Available from: https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-2/c/2009_01_12_readability_guideline_final_en.pdf. Accessed March 26, 2019.
   Google Scholar
• Thai food and drug administration. guideline for leaflet development for drug research and innovation 2019. Available form: https://www.fda.moph.go.th/sites/oss/SharedDocuments/SmPC-PIL_HPEPguideline_updatedMay2019.pdf. Accessed March 26, 2019.
   Google Scholar
• Phueanpinit P, Pongwecharak J, Krska J, Jarernsiripornkul N. Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand. Int J Clin Pharm. 2016;38(1):25–29. doi:10.1007/s11096-015-0220-2
   PubMed Web of Science ®Google Scholar
• Thai Food and Drug Administration. Guideline for Leaflet Development for Drug research and Innovation 2013. Available from: http://www.rapat.or.th/images/column_1344932177/ya-20131219-03.pdf. 19, August 2013. Accessed January 1, 2019.
   Google Scholar
• Division of Innovative Health Products. Patient information leaflets. 2022. Available from: https://www.fda.moph.go.th/sites/oss/SitePages/patientinformaionleafletpage2.aspx. Accessed November 22, 2022.
   Google Scholar
• Wongtaweepkij K, Krska J, Pongpunna S, Jarernsiripornkul N, Jarernsiripornkul N. Thai patients drug safety knowledge and perceptions relating to different forms of written medicine information: a comparative study. Patient Prefer Adherence. 2022;Volume 16:1141–1152. doi:10.2147/PPA.S361447
   Web of Science ®Google Scholar
• Ministry of Health Uganda. The national drug policy and authority (registration) regulations. 2014. Available from: https://www.nda.or.ug/wp-content/uploads/2022/03/Drug-Registration-Regulation.pdf. Accessed December 5, 2022.
   Google Scholar
• Mayora C, Kitutu FE, Kandala NB, Ekirapa-Kiracho E, Peterson SS, Wamani H. Private retail drug shops: what they are, how they operate, and implications for health care delivery in rural Uganda. BMC Health Serv Res. 2018;18(1):1–12. doi:10.1186/s12913-018-3343-z
   PubMedGoogle Scholar
• Ministry of Health Uganda. National drug authority. Available from: https://www.nda.or.ug/. Accessed November 22, 2022.
   Google Scholar
• Kalyango JN, Hall M, Karamagi C. Home medication management practices and associated factors among patients with selected chronic diseases in a community pharmacy in Uganda. BMC Health Serv Res. 2012;12(1). doi:10.1186/1472-6963-12-323
   PubMedGoogle Scholar
• The World Bank. Individuals using the Internet (% of population) - Thailand, Uganda, Malaysia, United Kingdom. 2022. Available from: https://data.worldbank.org/indicator/IT.NET.USER.ZS?locations=TH-UG-MY-GB. Accessed December 4, 2022.
   Google Scholar
• National Pharmaceutical Regulatory Agency (NPRA) Ministry of health Malaysia. drug registration guidance document (drgd) third edition, third revision 2022. Available from: https://www.npra.gov.my/index.php/en/component/sppagebuilder/925-drug-registration-guidance-document-drgd.html. 2022. Accessed November 22, 2022.
   Google Scholar
• Mittal P, Gan XY, Sim AY, et al. Adherence of safety information on over-the-counter product labels and leaflets to the regulatory guidelines in Malaysia. J Pharm Pract Res. 2018;48(3):204–211. doi:10.1002/jppr.1351
   Google Scholar
• Dawood OT, Hassali MA, Saleem F. Factors affecting knowledge and practice of medicine use among the general public in the state of Penang, Malaysia. J Pharm Heal Serv Res. 2017;8(1):51–57. doi:10.1111/jphs.12167
   Google Scholar
• Ting CY, Abd Wahab MS, Lee KS, Tan RTH, Ming LC. A cross-sectional study on the use of, preference for, and perceived reliability of mass media for drug-related information among the general public in Sarawak. Ther Innov Regul Sci. 2017;51(2):212–220. doi:10.1177/2168479016674041
   PubMed Web of Science ®Google Scholar
• Roter DL, Rudd RE, Comings J. Patient literacy, a barrier to quality of care. Commun Heal Educ. 1998;13:313–341.
   Google Scholar
• Nualdaisri P, Corlett SA, Krska J. The effectiveness and value of written medicine information across Asia and Africa: systematic review. Drug Saf. 2021;44(12):1283–1295. doi:10.1007/s40264-021-01114-7
   PubMed Web of Science ®Google Scholar